Clinical Characteristic | levels | N (375) | Percentage (%) |
---|---|---|---|
Gender | Female | 134 | 35.7 |
Male | 241 | 64.3 | |
Age |  <  = 65 | 164 | 44.2 |
 > 65 | 207 | 55.8 | |
T stage | T1 | 19 | 5.2 |
T2 | 80 | 21.8 | |
T3 | 168 | 45.8 | |
T4 | 100 | 27.2 | |
N stage | N0 | 111 | 31.1 |
N1 | 97 | 27.2 | |
N2 | 75 | 21 | |
N3 | 74 | 20.7 | |
M stage | M0 | 330 | 93 |
M1 | 25 | 7 | |
Pathologic stage | Stage I | 53 | 15.1 |
Stage II | 111 | 31.5 | |
Stage III | 150 | 42.6 | |
Stage IV | 38 | 10.8 | |
Primary therapy outcome | PD | 65 | 20.5 |
SD | 17 | 5.4 | |
PR | 4 | 1.3 | |
CR | 231 | 72.9 | |
Residual tumor | R0 | 298 | 90.6 |
R1 | 15 | 4.6 | |
R2 | 16 | 4.9 | |
Histologic grade | G1 | 10 | 2.7 |
G2 | 137 | 37.4 | |
G3 | 219 | 59.8 | |
H pylori infection | No | 145 | 89 |
Yes | 18 | 11 | |
Age, median (IQR) | Â | 67 (58, 73) | 67 (58, 73) |